Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)

ClinicalTrials.gov ID: NCT01938495

Public ClinicalTrials.gov record NCT01938495. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 4:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)

Study identification

NCT ID
NCT01938495
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Barrow Neurological Institute
Other
Enrollment
52 participants

Conditions and interventions

Interventions

  • NeuRx® Diaphragm Pacing System™ (DPS) Device

Device

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2013
Primary completion
Dec 31, 2016
Completion
Mar 31, 2017
Last update posted
Mar 8, 2023

2013 – 2017

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
24
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona
Cedars-Sinai Medical Center Los Angeles California
California Pacific Medical Center San Diego California
Stanford University Stanford California
Hospital for Special Care New Britain Connecticut
Mayo Clinic Florida Jacksonville Florida
University of Florida, Jacksonville Jacksonville Florida
University of Iowa Iowa City Iowa
Massachusetts General Hospital Boston Massachusetts
Henry Ford Health Systems Detroit Michigan
St Louis University St Louis Missouri
Neurology Associates P.C. Lincoln Nebraska
Hospital for Special Surgery New York New York
SUNY Upstate Medical University Syracuse New York
Carolinas Health Care Charlotte North Carolina
Wake Forest University Winston-Salem North Carolina
Cleveland Clinic Cleveland Ohio
Ohio State University Columbus Ohio
Providence ALS Center Portland Oregon
Drexel University Philadelphia Pennsylvania
University of Pittsburgh Pittsburgh Pennsylvania
University of Texas Southwestern Dallas Texas
University of Texas San Antonio Texas
University of Vermont Burlington Vermont
Virginia Mason Medical Center Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01938495, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2023 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01938495 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →